logo
The Summer Beauty Trends Worth Your Money—and the Ones to Skip

The Summer Beauty Trends Worth Your Money—and the Ones to Skip

June is to beauty routines what March is to basketball: It's prime time, baby. 'Summer brings a flood of new products as brands tap in to seasonal spending,' said Marina Peredo, a dermatologist in New York. This time of year, knowing which, if any, of the vaunted beauty aids to actually buy can feel like trying to book a last-minute Disney vacation. Overwhelming. 'Smart shopping helps you avoid gimmicks and save money—not everything is worth the hype.' For advice on what is worth it—and what's best left on the shelf—read on.
Those status gel manicures that last a whole pay cycle (and put a dent in one too)? Turns out they're not all that great for your nail health. It's the removal process—not the application—that damages nails. 'Prolonged acetone soaks will dehydrate the nail and cuticle, making the nail more prone to brittleness, peeling and breakage,' said Dana Stern, a New York dermatologist.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

One in four US adults with diabetes used a GLP-1 drug last year, survey finds
One in four US adults with diabetes used a GLP-1 drug last year, survey finds

Yahoo

time25 minutes ago

  • Yahoo

One in four US adults with diabetes used a GLP-1 drug last year, survey finds

By Bhanvi Satija (Reuters) -More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the U.S. Centers for Disease Control and Prevention said on Thursday. The wildly popular and effective GLP-1 drugs Mounjaro from Eli Lilly and Ozempic from Novo Nordisk are approved in the United States for treating type 2 diabetes. They are sold as Zepbound and Wegovy, respectively, for weight loss and are being tested for other conditions. Use of the injectable drugs was highest among adults with diabetes aged 50–64 at 33.3%, reflecting the more significant disease burden in this group, the report said. A quarter or 25.3% of adults with diabetes aged 18 to 34 reported using a GLP-1 drug, while the adoption rate was 20.8% among those 65 and older. The data are from a nationally representative annual survey of U.S. adults aged 18 and older that was conducted in person and with follow-up by phone in 2024. In 2024, for the first time, participants in the annual survey who had diabetes were asked if they were using the Lilly or Novo blockbusters or other GLP-1 drugs to lower blood sugar or lose weight. The drugs mimic the activity of a hormone that regulates blood sugar levels, slows digestion and helps people feel full for longer. Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply. Roughly 31% of survey participants who reported using insulin also reported using GLP-1 drugs, as did about 28% of patients who were using oral drugs to control their blood sugar, according to the report, indicating that these treatments are being integrated into combination regimens. Hispanic adults with diabetes had the highest rate of GLP-1 use, at 31.3%, followed by Black non-Hispanic and White non-Hispanic adults, at 26.5% and 26.2%, respectively, the survey found. Only 12.1% of Asian non-Hispanic adults with diabetes used the drugs, which may reflect disparities in access or adoption of the therapies. Solve the daily Crossword

At last, a humanoid robot masters the chore we all hate
At last, a humanoid robot masters the chore we all hate

Digital Trends

time26 minutes ago

  • Digital Trends

At last, a humanoid robot masters the chore we all hate

A couple of weeks ago, we watched in awe as Figure's humanoid robot grabbed clothes from a laundry basket before deftly depositing them in a washer. It was all very impressive. In a follow-up that offers a glimpse of a future where humans can finally ignore this wretched chore, Figure has shared another video showing the same robot folding freshly washed towels before placing them in a pile. Today we unveiled the first humanoid robot that can fold laundry autonomously Same exact Helix architecture, only new data — Figure (@Figure_robot) August 12, 2025 The California-based tech company said it's the first humanoid robot capable of folding laundry 'fully autonomously,' a statement that will surely cause millions of people around the world to call out at once: 'So where can I get one?' Well, more on that later. Recommended Videos To conduct the process, Figure 02 uses the same Helix Vision Language Action (VLA) model that the company has already deployed for industrial logistics tasks, but now with a new dataset for laundry folding. To be clear, the robot performs the laundry task without teleoperation or specialized hand-coded instructions, relying instead on an end-to-end neural network. As you can see, the robot uses multi-fingered hands to competently pick towels from a pile. It also performs different folding strategies, recovers from errors such as grabbing multiple towels at once, and carries out fine manipulations — just like a human. The video demonstrates real advances in one of the areas that robotics engineers still find extremely challenging: manipulation of objects, especially soft, flexible ones. Indeed, the robot's impressive ability to handle the humble towel looks like an exciting step toward such machines being able to cope with other non-rigid items, opening them up to a plethora of other tasks in a broader range of settings. 'Folding laundry sounds mundane for a person, but this is one of the most challenging dexterous manipulation tasks for a humanoid robot,' Figure said in a post on its website. 'Towels are deformable, constantly changing shape, bending unpredictably, and prone to wrinkling or tangling. There's no fixed geometry to memorize, and no single 'correct' grasp point. Even a slight slip of a finger can cause the material to bunch or fall. Success requires more than just seeing the world accurately — it demands fine, coordinated finger control to trace edges, pinch corners, smooth surfaces, and adapt in real time.' While Figure is currently focused on deploying its humanoid robot in industrial locations, it will — tantalizingly for all of those laundry haters out there — begin testing it in home settings this year. Figure has yet to mention pricing and other purchasing details for individual customers, so for the time being at least, the laundry will continue as a regular chore for most folks. But this humanoid robot certainly offers hope …

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store